-
公开(公告)号：EP1482924A2
公开(公告)日：2004-12-08
申请号：EP03716238.5
申请日：2003-02-28
发明人： BAYLY, Christopher, I. , BLACK, Cameron , LEGER, Serge , LI, Chun Sing , MCKAY, Dan , MELLON, Christophe , GAUTHIER, Jacques Yves , LAU, Cheuk , THERIEN, Michel , TRUONG, Vouy-Linh , GREEN, Michael, J. , HIRSCHBEIN, Bernard, L. , JANC, James, W. , PALMER, James, T. , BASKARAN, Chitra
IPC分类号： A61K31/275
CPC分类号： C07C237/20 , A61K31/165 , A61K31/18 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4418 , A61K31/495 , C07C255/25 , C07C255/29 , C07C255/46 , C07C255/58 , C07C259/10 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/14 , C07D209/08 , C07D213/38 , C07D213/57 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/64 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D277/30 , C07D295/135 , C07D295/155 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04
摘要： This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
-
公开(公告)号：EP1537074A1
公开(公告)日：2005-06-08
申请号：EP03793540.0
申请日：2003-09-03
发明人： BOYD, Michael , GAGNON, Marc , LAU, Cheuk , MELLON, Christophe , SCHEIGETZ, John
IPC分类号： C07C255/25 , C07D295/096 , C07D213/30 , C07C317/22 , C07F5/02 , C07D241/16 , C07D277/24 , C07C311/29 , C07D215/14 , C07D239/26 , C07D209/12 , C07C259/10 , C07C255/54 , A61K31/275 , A61K31/495
CPC分类号： C07C255/29 , C07C255/25 , C07C255/54 , C07C259/10 , C07C311/29 , C07C317/22 , C07C317/24 , C07C317/44 , C07C323/19 , C07C323/22 , C07C323/60 , C07C2601/02 , C07C2601/14 , C07C2601/16 , C07D211/22 , C07D211/94 , C07D213/30 , C07D213/61 , C07D213/79 , C07D213/89 , C07D215/14 , C07D215/60 , C07D233/22 , C07D239/26 , C07D241/16 , C07D277/24 , C07D295/088 , C07D295/192 , C07D295/205 , C07D295/26 , C07D333/16 , C07D401/04
摘要： This invention relates to class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis. They have the following structure: Formula (I)
摘要翻译： 本发明涉及半胱氨酸蛋白酶抑制剂的类别，包括但不限于组织蛋白酶K，L，S和B的抑制剂。这些化合物可用于治疗其中指示骨吸收抑制的疾病，例如骨质疏松症。 它们具有以下结构：式（I）
-
公开(公告)号：EP1482924B1
公开(公告)日：2008-05-21
申请号：EP03716238.5
申请日：2003-02-28
发明人： BAYLY, Christopher, I. , BLACK, Cameron , LEGER, Serge , LI, Chun Sing , MCKAY, Dan , MELLON, Christophe , GAUTHIER, Jacques Yves , LAU, Cheuk , THERIEN, Michel , TRUONG, Vouy-Linh , GREEN, Michael, J. , HIRSCHBEIN, Bernard, L. , JANC, James, W. , PALMER, James, T. , BASKARAN, Chitra
IPC分类号： A61K31/275 , C07C255/25 , C07C255/46 , C07C311/37 , C07C317/32 , C07D209/08 , C07D213/38 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/54 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D295/12 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04 , A61P19/00
CPC分类号： C07C237/20 , A61K31/165 , A61K31/18 , A61K31/4174 , A61K31/426 , A61K31/44 , A61K31/4418 , A61K31/495 , C07C255/25 , C07C255/29 , C07C255/46 , C07C255/58 , C07C259/10 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/14 , C07D209/08 , C07D213/38 , C07D213/57 , C07D213/64 , C07D213/70 , C07D213/89 , C07D215/12 , C07D231/12 , C07D233/64 , C07D239/26 , C07D241/12 , C07D261/08 , C07D263/32 , C07D271/06 , C07D277/28 , C07D277/30 , C07D295/135 , C07D295/155 , C07D307/52 , C07D333/20 , C07D401/04 , C07D417/04
摘要： This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
摘要翻译： 本发明涉及一类新的化合物，它们是半胱氨酸蛋白酶抑制剂，包括但不限于组织蛋白酶K，L，S和B的抑制剂。这些化合物可用于治疗其中指出骨吸收抑制的疾病，例如 骨质疏松症。
-
-
搜索结果
3 条记录 (耗时 0.016 秒)
